# Widecells Group Plc Q&A with CEO João Andrade & WideAcademy VP Alan Greenberg (LON:WDC)

- Link: https://www.directorstalkinterviews.com/widecells-group-plc-qa-ceo-joao-andrade-wideacademy-vp-alan-greenberg-lonwdc/412730393
- Published: 2017-06-15T12:53:45+01:00
- Author: Amilia Stone

**Widecells Group Plc** (LON:WDC) Chief Executive Officer João Andrade and Vice 
President of Wide Academy Alan Greenberg caught up with DirectorsTalk for an exclusive
interview to discuss the WideAcademy strategy, background of WideAcademy’s VP Alan
Greenberg and where the company will be in 12-18 months

 

**Q1: Now, there’s been great success with CellPlan recently in expanding its global
reach but in what manner is the success of Widecells predicted on that of WideAcademy
and vice versa?**

**A1**: Well, the success for Widecells, not only Widecells but if you look at everyone
involved in the industry, are thinking about the patients first. Ultimately, there’s
a lack of information today about the benefits of stem cell technology and the mandate
that Alan has at WideAcademy is really to educate the world. That’s important to
Widecells because if medical professionals understand the benefits of a family storing,
for example, their umbilical cord blood stem cells to protect them in the future
and when they need to use it, if they know all the medical teams involved, where
the treatments centres are and how is the process of accessing their treatment or
even transporting a sample from point A to point B. If there’s enough information
so that people can make an informed decision, we believe that more people can benefit
the technology and it’s a win/win situation for everyone involved.

 

**Q2: So, Alan, in layman’s terms, what is the mandate for WideAcademy?**

**A2**: The brief I’ve been given from João and the directors is to build trusted
and authentic set of content that people can come to and rely on and actually access
intuitively, easily and make it available to them on any device. The long and short
of it is if you want to do research, if you want to look onto the web and find out
what stem cell innovation is or is not, there’s a lot of stuff which is perhaps 
not as good a content as it needs to be, there’s very good research but who wants
to read the research paper. So, part of our responsibility is disseminating that
research content into consumable media that people can look at and consider, we’re
also building a podcast series so that podcast series will be audio content and 
interweaved with thought leaders part of the community that are building up WideAcademy
and really helping to make that content available on a global basis, initially in
the English language but in multiple languages at a time.

 

**Q3: So, how do medical professionals and families access information on cutting-
edge stem cell technology currently?**

**A3**: I’ll give you an example of what we’re going to do as I would argue that
I’m not sure the information is out there today, I think the opportunity is almost
like a sheet of paper. Our ability to reach out into the medical world, and by that
I mean if you consider every existing GP, not just in the United Kingdom but globally,
probably was not educated or had any great insight when he was taught in university
or medical school on stem cells. We need to support that particular channel to market
and help GP’s and doctors understand what that innovation is all about, equally 
we will work with medical schools and universities looking at the next generation
of doctors/nurses/midwives and supporting with courseware the opportunity to support
that education and journey. So, literally providing a trusted resource for education
content for this sector in a way that, probably, has not been done previously. The
other thing that’s interesting, and we’ve got some technology people and some research
people looking at this problem, they found out recently that the budget of circa
£2,000 a year that every doctor has in the country for continued professional development
for lifelong learning, we want to tap into that budget. We want to be part of that
trusted resource to support doctors in that learning journey, I’ll repeat again,
not just in the United Kingdom but on a global basis.

Our second, we’re equally looking into enterprise so I would argue that CellPlan
is a very important product in the market place, it will be sold by insurance brokers,
again on a global basis, we want to provide education resources, trusted resources
for those brokers so that when they speak to their end-user, their customers, and
then they approach the CellPlan product in the market place, they have some deep
authentic content to refer to and some references that they can speak with some 
authority.

The third cohort, which is obvious, is the consumers themselves and provide that
trust of channel for content available to the individual, to families, to be able
to access that content, e Equally, perhaps, to the older generation because we know
that the market for maybe parents or grandparents providing this stem cell opportunity
to their children or grandchildren.

So, it’s a broad remit on a global basis with easily accessible, intuitive content.

 

**Q4: Alan, you were brought on board to do just that, how do you intend to leverage
this to increase awareness of stem cells? Can you also give us a little bit more
information on your background?**

**A4**: How much time do I have? Have you got a couple of hours? I’m happy to give
you further detail, assuming you’d want a shorter version.
 In a brief synopsis,
I was Apple’s Education Director between 2004-2010, my team with Apple built products
like podcasting, I recently met with some colleagues there that I worked with in
London and found out that the work that my team started in London has now over 10
billion downloads. I had to look up Wikipedia to work out that it’s 10 plus 9 zeros,
I actually didn’t know how many zeros there were so I had a little bit of impact
in terms of dissemination and distribution of digital content. I then worked on 
something called iTunes U where Apple provides universities with a portal to publish
their education content, I also worked on the App Store and some of the early generation
of education healthcare apps.

After leaving Apple Inc. (NASDAQ:AAPL), I started working with Venture Capital and
young innovative education healthcare start-up’s so I have a little bit of experience
in terms of building these sorts of technology capabilities and building engagement
which is fairly deep and fairly broad and international.

 

**Q5: So, who have you got working with you on all of this?**

**A5**: I was asked this earlier, I don’t like talking about people because their
egos will get too big but I managed to secure a long-time friend who was originally
the Editor of Guardian Education online, he then went to The Independent, he worked
also for Tony Blair’s 10 Downing Street building authorities of engagement at 10
Downing Street, he then went on to the Foreign and Commonwealth Office and built
digital diplomacy. He is a master of digital content and the distribution channels,
we’ve collaborated for over 12 years, I’m lucky to have Jimmy Leach on board helping
and supporting me with the education side of things.

We’ve also brought in a VP of Enterprise, again common experience in financial services
and actually in training up of insurance brokers, that young lady is coming on board
to build the enterprise division, again working across the portfolio content and
distribution channels we’re looking at.

 

**Q6: Where do you see WideAcademy in the next 6-12 months and perhaps the next 
12-18 months?**

**A6**: One word, global. We will deliver the content initially, again to be clear,
I don’t want to talk too much in detail today about what we’re delivering but it
will be fundamentally in English language first, so you could sort of say the greatest
network of web environments but we’re already looking at building out international
languages, we’re looking into Spanish and Portuguese, we recognise South America
as a huge opportunity for the company in general, we’re also already looking into
Chinese language and Asian areas as well. So, we will be a global distribution company
within months, certainly within the next 12-18 months.

Share on:
